Document is current
Any future updates will be listed below
-
Authors
Gromisch, Christopher M.
Tan, Glaiza L. A.
Pasion, Khristine Amber
Moran, Ann-Marie
Gromisch, Matthew S.
Grinstaff, Mark W.
Carr, Francis J.
Herrera, Victoria L. M.
Ruiz-Opazo, Nelson
- License Information
-
More Information
Article History
Received: 28 December 2020
Accepted: 23 March 2021
First Online: 14 April 2021
Declarations
:
: All animal model studies were done in compliance with Boston University IACUC approved protocol AN15160 to V. Herrera and N. Ruiz-Opazo, and in compliance with ARRIVE 2.0 (Additional file-InternalRef removed: Supplemental Methods and Materials).
: Boston University holds awarded and pending patents on DEspR. Victoria L. M. Herrera, Nelson Ruiz-Opazo, and Francis J. Carr are co-inventors filed by Boston University. These patents comprise the option granted for exclusive license to NControl Therapeutics, Inc. VLMH, NRO, FCJ are scientific co-founders of Abtelum Biomedical Therapeutics, now NControl Therapeutics. VLMH, NRO, FCJ are paid consultants > $10,000 and scientific co-founders, with equity > 5%, of NControl Therapeutics, Inc. NControl Therapeutics was not involved in the funding, design, conception, data interpretation, or manuscript preparation. All other co-authors have no competing interests.
